February 2017 Issue of The Cannabis Scientist

How software could enhance transparency in cannabis cultivation – and help speed up the legalization process

What does legalizing medical cannabis mean for conventional pharmaceuticals?

Could cannabis come to the rescue in the midst of an “opioid epidemic”?

A new analytical approach can detect trace levels of cannabis in breast milk

Joshua Crossney updates us about the events that are getting the medicinal cannabis industry talking.

To keep cannabis consumers safe, tests for pesticide residues must use multiple methods.

As cannabis takes its rightful place as an important botanical medicine, it’s time to consign the term ‘marijuana’ to the history books.

By improving knowledge about cannabis, we can help consumers make the best decisions for them – and make the most of the benefits.

An interview with Alisha Holloway, Director of Bioinformatics at Phylos Bioscience, Portland, Oregon and Assistant Adjunct Professor, Department of Epidemiology and Biostatistics, University of California, San Francisco (UCSF), USA.

An Interview with Daniela Vergara, postdoctoral researcher at the University of Colorado, Founder and President of the Agricultural Genomics Foundation, and co-Founder of the Cannabis Genomic Research Institute, Boulder, CO, USA.

An interview with Kevin A Schug, Professor and Shimadzu Distinguished Professor of Analytical Chemistry at the University of Texas in Arlington, USA.

Sitting Down With…Robert Martin, Chief Operating Officer of CW Analytical and Executive Director of the Association of Commercial Cannabis Laboratories (ACCL), Oakland, CA, USA.